NAVBQ (Navidea Biopharmaceuticals) Pretax Margin %: % (As of Sep. 2023)

What is Navidea Biopharmaceuticals Pretax Margin %?

Navidea Biopharmaceuticals NAVBQ 16 Pretax Margin % is % as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Navidea Biopharmaceuticals's Pre-Tax Income for the three months ended in Sep. 2023 was $-2.26 Mil. Navidea Biopharmaceuticals's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Navidea Biopharmaceuticals's pretax margin for the quarter that ended in Sep. 2023 was %.

The historical rank and industry rank for Navidea Biopharmaceuticals's Pretax Margin % or its related term are showing as below:

NAVBQ's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Navidea Biopharmaceuticals (OTCPK:NAVBQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Navidea Biopharmaceuticals Pretax Margin % Related Terms

Navidea Biopharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals Pretax Margin % Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pretax Margin %

Get a 7-Day Free Trial

-5,005.88

-40,537.04

-9,010.08

-25,467.39

-101,180.00

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Pretax Margin %	Get a 7-Day Free Trial															-71,350.00	-348,200.00	0.00	0.00	0.00

NAVBQ vs PKBO, RSPI, ATRX: Pretax Margin % Comparison

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navidea Biopharmaceuticals Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Pretax Margin % falls into.

Save Embed

16GF Score

Navidea Biopharmaceuticals Inc NAVBQ

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Navidea Biopharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Navidea Biopharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-15.177	/	0.015
	=	-101,180.00 %

Navidea Biopharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-2.255	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Navidea Biopharmaceuticals (NAVBQ) has a Pretax Margin % of % as of Sep. 2023. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Navidea Biopharmaceuticals and its competitors.

Is Navidea Biopharmaceuticals' Pretax Margin % too high?

Navidea Biopharmaceuticals' current Pretax Margin % is %. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.

How does Navidea Biopharmaceuticals' Pretax Margin % compare to PKBO and RSPI?

Navidea Biopharmaceuticals' Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Navidea Biopharmaceuticals and its competitors. Navidea Biopharmaceuticals's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Navidea Biopharmaceuticals stock overvalued right now?

Navidea Biopharmaceuticals (NAVBQ) has a current Pretax Margin % of %. The current Pretax Margin % is %. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current Pretax Margin % is % as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies PKBO RSPI ATRX ARDS NYMXF CNBX IVRN ATHXQ EMMA BTTX OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

16GF Score

Get the complete analysis for NAVBQ

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View NAVBQ Analysis

See Pretax Margin % data for all stocks →